Food group Nestle has taken a further step into the medicine business by signing a research collaboration agreement with a Swiss biotech company to develop an Alzheimer’s disease diagnostic test.
Nestle’s second medical deal in a week underscores the commitment by the world’s largest packaged food company to the faster-growing, more profitable medical field as sales of processed foods slow in many markets.
Swiss biotech firm AC Immune, which already has established ties with Roche in drug research, said on Wednesday it would develop a minimally invasive diagnostic assay for Tau with the Nestle Institute of Health Sciences. Financial terms were not disclosed.
Help employers find you! Check out all the jobs and post your resume.
